MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-08-0004482
Siba Life Sciences Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹44.3 Lakh
▼ 44% YoY
Net profit · FY 2024
₹46,929
Net margin 1.1%
EBITDA · FY 2024
₹80,084
EBITDA margin 1.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
15 yrs
Est. 2011
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Siba Life Sciences Limited
Data last updated:
Siba Life Sciences Limited is a public limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 November 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51102DL2011PLC227340. Its GSTIN is 07AAQCS5941K1ZP (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Syed Firdos Imam Rizvi and Syed Misam Imam Rizvi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No. 50 Ground Floor Bharat Nagar New Friends Colony, New Delhi, Delhi, India – 110065.
As per the financials filed for FY 2024, the company reported a revenue of ₹44.3 Lakh, a decline of 44% compared to the previous year. For the same year it recorded a net profit of ₹46,929 (net margin 1.1%) and EBITDA of ₹80,084 (EBITDA margin 1.8%). Revenue has declined at a compounded annual rate (CAGR) of 26% over three years and 20% over five years.
Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
Siba Life Sciences Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0004482). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sibalife.com.
Company details
CIN U51102DL2011PLC227340
Registration Number 227340
Incorporation Date 11 November 2011
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-08-0004482
Key People
Syed Firdos Imam Rizvi Director Syed Misam Imam Rizvi Director Syed Qaiser Mehdi Rizvi Additional Director Recognitions & Rankings of Siba Life Sciences
Contact details
Siba Life Sciences Limited's registered office is in New Delhi, Delhi. Its website is sibalife.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressH. No. 50 Ground Floor Bharat Nagar New Friends Colony, New Delhi, Delhi, India – 110065
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Siba Life Sciences Limited, buy the company report.
Comprehensive company report
Siba Life Sciences Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Siba Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Siba Life Sciences Limited, buy the company report.
Financials of Siba Life Sciences Limited
FY 2025 filings availableSiba Life Sciences Limited reported revenue of ₹44.3 Lakh (down 44% YoY) for FY 2024.
Revenue · FY 2024
₹44.3 Lakh ▼ 44%
Net profit · FY 2024
₹46,929 margin 1.1%
EBITDA · FY 2024
₹80,084 margin 1.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 44%
3 years · compounded
▼ 26%
5 years · compounded
▼ 20%
EBITDA CAGR growth
1 year
▼ 56%
3 years · compounded
▼ 59%
5 years · compounded
▼ 44%
Revenue has declined at a compounded annual rate (CAGR) of 20% over five years, including a 44% fall in the latest year. EBITDA fell 56% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹80,084 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹46,929 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Siba Life Sciences Limited, buy the company report.
Board of directors of Siba Life Sciences Limited
Siba Life Sciences has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Syed Firdos Imam Rizvi Also directs: Oncomed Marketing Private Limited | Director | 11 Nov 2011 | 14 Years 11 Months | Current |
| Syed Misam Imam Rizvi | Director | 31 Mar 2015 | 11 Years 6 Months | Current |
| Syed Qaiser Mehdi Rizvi Also directs: Maxicare Technical Contracting Private Limited | Additional Director | 04 Sep 2015 | 11 Years 1 Months | Current |
Peer comparison
Siba Life Sciences Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Arka Biologics Private Limited | ₹44.33 Lakh (FY 2016) | -71.0% | Ahmedabad, Gujarat, India | |||
| Siba Life Sciences Limitedthis company | ₹44.3 Lakh (FY 2024) | ₹46,929 | 1.1% | -44.0% | New Delhi, Delhi, India | |
| Medirize Pharmaceuticals Private Limited | ₹44.27 Lakh (FY 2018) | 8.0% | Hyderabad, Telangana, India | |||
| Moxy Laboratories Private Limited | ₹44.24 Lakh (FY 2024) | -18.0% | Vadodara, Gujarat, India | |||
| Ultra Chiron Healthcare Private Limited | ₹44.19 Lakh (FY 2025) | -31.0% | Punjab, India |
To see the full peer comparison of Siba Life Sciences Limited, buy the company report.
Auditor
Siba Life Sciences Limited is audited by MOHIT KUMAR AND CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MOHIT KUMAR AND CO | FY 2021 | 030836N |
Shareholding
The shareholding of Siba Life Sciences Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Siba Life Sciences Limited, buy the company report.
Legal cases
Siba Life Sciences Limited has 1 court case on record: 1 filed by Siba Life Sciences. All case is pending.
Total cases
1
Filed by the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Criminal case | Filed by the company against M/S Patient Mitra Medicals | Pending |
To see the full case history of Siba Life Sciences Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Siba Life Sciences Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Siba Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAQCS5941K1ZP | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Siba Life Sciences Limited, buy the company report.
Recent activity
Siba Life Sciences Limited has 12 board changes on record since 2011: 3 appointments and 9 cessations. The latest: Ammar Ahmad Khan ceased to be Director on 01 Oct 2019.
AGM
Siba Life Sciences Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Siba Life Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Ammar Ahmad Khan ceased to be Director.
Ceased
Seema Saxena ceased to be Director.
Ceased
Matiulla ceased to be Director.
Ceased
Prani Sharma ceased to be Director.
Ceased
Barnali Chakraborty ceased to be Director.
Appointed
Syed Qaiser Mehdi Rizvi was appointed as Additional Director.
Appointed
Syed Misam Imam Rizvi was appointed as Director.
Ceased
Arun Kapoor ceased to be Director.
Ceased
Rajiv Nath Rekhi ceased to be Director.
Ceased
Iqbal Shahanshah Abidi ceased to be Director.
3 earlier events are in the company report.
Frequently asked questions
Siba Life Sciences is an active public limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 November 2011 (15+ years old) and is registered under CIN U51102DL2011PLC227340.
Siba Life Sciences has 3 current directors:
- Syed Firdos Imam Rizvi - Director
- Syed Misam Imam Rizvi - Director
- Syed Qaiser Mehdi Rizvi - Additional Director
The latest financial statements of Siba Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Siba Life Sciences is 07AAQCS5941K1ZP, registered in Delhi.
The CIN (Corporate Identification Number) of Siba Life Sciences is U51102DL2011PLC227340. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Siba Life Sciences has 1 court case on record: 1 filed by the company. 1 is pending.
Siba Life Sciences was incorporated on 11 November 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Siba Life Sciences by revenue are Arka Biologics Private Limited, Medirize Pharmaceuticals Private Limited, Moxy Laboratories Private Limited, Ultra Chiron Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Ammar Ahmad Khan ceased to be Director on 01 Oct 2019. Seema Saxena ceased to be Director on 22 Apr 2019. Matiulla ceased to be Director on 23 Nov 2018. Siba Life Sciences has 12 board changes on record in total.
Yes, Siba Life Sciences is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-08-0004482).
Siba Life Sciences can be reached through the website sibalife.com. Its registered office is in New Delhi, Delhi, India.